{"schema_version":"secwatch.filing_event.v1","accession":"0001801170-26-000071","form_type":"8-K/A","ticker":"CLOV","cik":"0001801170","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","filed_at":"2026-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.218391+00:00","generated_at":"2026-05-15T18:51:52.929787+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Clover Health publishes supplemental shareholder Q&A; no new financial data disclosed","bullets":["Filed 8-K/A on March 6, 2026 furnishing a supplemental Q&A document related to Q4 2025 earnings.","Document contains selected responses to shareholder questions but includes no specific financial or operational metrics.","CEO Andrew Toy reaffirms commitment to shareholder transparency in the accompanying letter.","Q&A is also available on the investor relations page of Clover Health's website."],"urls":{"canonical":"https://secwatch.observer/filing/0001801170-26-000071","json":"https://secwatch.observer/filing/0001801170-26-000071.json","markdown":"https://secwatch.observer/filing/0001801170-26-000071.md","text":"https://secwatch.observer/filing/0001801170-26-000071.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1801170/000180117026000071/0001801170-26-000071-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1801170/000180117026000071/clov-20260306.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T18:51:52.929787+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}